Russian company "Promomed" begins testing HIV drug
The molecule will be used in humans for the first time - it blocks the integration of the virus into cell DNA
«Promomed»
Clinical trials of peptide cancer vaccine planned to start in Russia in 2027
The drug will be tested directly on patients, because such developments are not tested on healthy volunteers